Document Detail


Neuropathologic substrate of mild cognitive impairment.
MedLine Citation:
PMID:  16401735     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
OBJECTIVE: To define the neuropathologic findings in amnestic mild cognitive impairment (MCI) and early Alzheimer disease (EAD). METHODS: The mean numbers of diffuse plaques, neuritic plaques (NPs), and neurofibrillary tangles (NFTs) in 4 neocortical regions and 4 ventromedial temporal lobe regions were counted in 10 patients with amnestic MCI and compared with the mean numbers in 23 normal control subjects and 10 patients with EAD, and then were compared with memory performance. All of the controls and patients were followed longitudinally. RESULTS: Patients with MCI showed no significant difference (P>.05) in the number of diffuse plaques from that in normal controls or patients with EAD. In patients with MCI, the number of NPs was significantly elevated in all 4 neocortical regions and amygdala compared with controls (P<.01 to <.001). There were no significant differences (P>.05) in the number of NPs between MCI and EAD cerebral cortex, but significant increases were present for NPs in EAD amygdala and subiculum compared with MCI (P<.01). In patients with MCI compared with controls, the only significant increase in NFTs in the neocortex was in the parietal lobe. However, the number of NFTs was significantly elevated in MCI in all 4 ventromedial temporal lobe structures compared with controls (P<.01 to <.001). In comparing MCI with EAD, there were significant increases in NFTs in EAD in frontal and temporal lobes, amygdala, and subiculum (P<.01). The numbers of NPs and NFTs were significantly elevated in all of the neocortical regions and ventromedial temporal lobe regions in patients with EAD compared with controls (P<.001). Memory function was significantly correlated with NFTs in CA1 of the hippocampus (P<.01) and the entorhinal cortex (P<.05). CONCLUSIONS: In patients with amnestic MCI who were followed longitudinally, the early changes of Alzheimer disease were present. The NFTs were slightly more prominent than beta-amyloid peptide deposition in the progression from normal to MCI to EAD. Ventromedial temporal lobe NFTs probably represent the substrate for memory decline in MCI. From a neuropathologic perspective, it appears that amnestic MCI is, in reality, EAD.
Authors:
William R Markesbery; Frederick A Schmitt; Richard J Kryscio; Daron G Davis; Charles D Smith; David R Wekstein
Related Documents :
8082615 - Differentiation of temporal lobe ictal behavior associated with hippocampal sclerosis a...
10511785 - Temporal lobectomy for intractable complex partial seizures in pediatric patients.
12223035 - Manual approach during hand gesture imitation.
15990725 - The quest of cavum septi pellucidi: obscure chance event discovery or the result of som...
24719135 - Antiplatelet effect of clopidogrel can be reduced by calcium-channel blockers.
24852925 - Extensive cerebral white matter involvement in a patient with nmo spectrum disorder.
Publication Detail:
Type:  Comparative Study; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Archives of neurology     Volume:  63     ISSN:  0003-9942     ISO Abbreviation:  Arch. Neurol.     Publication Date:  2006 Jan 
Date Detail:
Created Date:  2006-01-10     Completed Date:  2006-03-02     Revised Date:  2007-11-14    
Medline Journal Info:
Nlm Unique ID:  0372436     Medline TA:  Arch Neurol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  38-46     Citation Subset:  AIM; IM    
Affiliation:
Alzheimer's Disease Center, University of Kentucky, Lexington, KY 40536-0230, USA. wmark0@email.uky.edu
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Aged
Aged, 80 and over
Alzheimer Disease / complications,  pathology*
Cognition Disorders / etiology,  pathology*
Demography
Female
Humans
Male
Memory / physiology
Neocortex / pathology
Neurofibrillary Tangles / pathology*
Neuropsychological Tests / statistics & numerical data
Senile Plaques / pathology*
Temporal Lobe / pathology
Grant Support
ID/Acronym/Agency:
5-P50-AG05144/AG/NIA NIH HHS
Comments/Corrections
Comment In:
Arch Neurol. 2006 Jan;63(1):15-6   [PMID:  16401731 ]

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Insights into the molecular pathogenesis of progression in multiple sclerosis: potential implication...
Next Document:  A 24-week open-label extension study of memantine in moderate to severe Alzheimer disease.